LTBR vs LYEL
Comparison between Lightbridge Corp (LTBR, Company) and Lyell Immunopharma Inc (LYEL, Company).
LTBR is from the Industrials sector, while LYEL is from the Healthcare sector.
5-Year PerformanceLTBR has outperformed LYEL, delivering a return of +7.4% compared to -45.9%
LTBR vs LYEL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LTBR vs LYEL - Historical Returns
Returns include dividend reinvestment.
LTBR vs LYEL - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | LTBR | LYEL |
|---|---|---|
| 2026 | -38.20% | -52.59% |
| 2025 | +147.84% | +138.60% |
| 2024 | +41.62% | -69.67% |
| 2023 | -16.41% | -42.26% |
| 2022 | -48.06% | -54.94% |
| 2021 | +59.25% | -54.17% |
| 2020 | -13.14% | N/A |
| 2019 | -34.22% | N/A |
| 2018 | -56.75% | N/A |
| 2017 | +6.09% | N/A |
| 2016 | -76.25% | N/A |
| 2015 | -36.31% | N/A |
| 2014 | -4.32% | N/A |
| 2013 | -2.68% | N/A |
| 2012 | -34.30% | N/A |
| 2011 | -63.31% | N/A |
| 2010 | -17.54% | N/A |
| 2009 | +24.79% | N/A |
| 2008 | -60.00% | N/A |
| 2007 | +26.67% | N/A |
| 2006 | +57.89% | N/A |
| 2005 | +46.15% | N/A |
| 2004 | +366.67% | N/A |
| 2003 | -33.33% | N/A |
| 2002 | +0.00% | N/A |
| 2001 | -98.00% | N/A |
| 2000 | +10.40% | N/A |
LTBR vs LYEL Drawdown Comparison
The maximum drawdown for LTBR was -99.96%, occurring on Apr 7, 2020. This drawdown has not yet recovered.
The maximum drawdown for LYEL was -97.83%, occurring on May 14, 2025. This drawdown has not yet recovered.
The current LTBR drawdown is -99.78%. The current LYEL drawdown is -96.17%.
| Rank | LTBR | LYEL |
|---|---|---|
| #1 | -99.96% Dec 6, 2000 - Apr 7, 2020 | -97.83% Sep 10, 2021 - May 14, 2025 |
| #2 | N/A | -20.11% Jul 16, 2021 - Sep 7, 2021 |
| #3 | N/A | -9.71% Jun 17, 2021 - Jul 16, 2021 |
| #4 | N/A | -1.11% Sep 8, 2021 - Sep 10, 2021 |
Correlation
Correlation between LTBR and LYEL is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks